For the first time, it has now become clear that RIPK3 acts as an epigenetically regulated tumor suppressor in melanoma; its re- or overexpression likely causes an induction of necroptosis, which results in an inhibition of tumor cell proliferation in melanoma and HEK. The gene discussed is RIPK3; the disease is neoplasm.